Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Geoerger

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Molecular Therapy. Nucleic Acids|March 23, 2017
Relevance of Fusion Genes in Pediatric Cancers: Toward Precision MedicineCélia Dupain, Anne Catherine Harttrampf, Giorgia Urbinati, et al.
The Lancet. Oncology|December 1, 2023
A new generation of comprehensive precision oncology trialsBirgit Geoerger, Francisco Bautista, Susanne A Gatz, et al.
Frontiers in Cell and Developmental Biology|September 8, 2022
Insight into the interplay between mitochondria-regulated cell death and energetic metabolism in osteosarcomaHong Toan Lai, Nataliia Naumova, Antonin Marchais, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2013
A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults' trialsXavier Paoletti, Birgit Geoerger, François Doz, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2025
Fighting sarcomas at the root: The role of mesenchymal stem cells in sarcomagenesisMargaux Chantoiseau, Maria Eugénia Marques da Costa, Birgit Geoerger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2009
High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignanciesMelissa Taylor, Jochen Rössler, Birgit Geoerger, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer ConsortiumFrancisco Bautista, Lucas Moreno, Lynley Marshall, et al.
Oncogene|September 7, 2019
Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progressionCélia Dupain, Céline Gracia, Anne C Harttrampf, et al.
Pediatric Blood & Cancer|August 9, 2005
p53 Pathway dysfunction in primary childhood ependymomasNathalie Gaspar, Jacques Grill, Birgit Geoerger, et al.
Anticancer Research|May 6, 2009
EGFR inhibition using gefitinib is not active in neuroblastoma cell linesJochen Rössler, Eva Odenthal, Birgit Geoerger, et al.
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Molecular Therapy. Nucleic Acids|March 23, 2017
Relevance of Fusion Genes in Pediatric Cancers: Toward Precision MedicineCélia Dupain, Anne Catherine Harttrampf, Giorgia Urbinati, et al.
The Lancet. Oncology|December 1, 2023
A new generation of comprehensive precision oncology trialsBirgit Geoerger, Francisco Bautista, Susanne A Gatz, et al.
Frontiers in Cell and Developmental Biology|September 8, 2022
Insight into the interplay between mitochondria-regulated cell death and energetic metabolism in osteosarcomaHong Toan Lai, Nataliia Naumova, Antonin Marchais, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2013
A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults' trialsXavier Paoletti, Birgit Geoerger, François Doz, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2025
Fighting sarcomas at the root: The role of mesenchymal stem cells in sarcomagenesisMargaux Chantoiseau, Maria Eugénia Marques da Costa, Birgit Geoerger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2009
High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignanciesMelissa Taylor, Jochen Rössler, Birgit Geoerger, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer ConsortiumFrancisco Bautista, Lucas Moreno, Lynley Marshall, et al.
Oncogene|September 7, 2019
Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progressionCélia Dupain, Céline Gracia, Anne C Harttrampf, et al.
Pediatric Blood & Cancer|August 9, 2005
p53 Pathway dysfunction in primary childhood ependymomasNathalie Gaspar, Jacques Grill, Birgit Geoerger, et al.
Anticancer Research|May 6, 2009
EGFR inhibition using gefitinib is not active in neuroblastoma cell linesJochen Rössler, Eva Odenthal, Birgit Geoerger, et al.
Pageof 18